LISATA THERAPEUTICS, INC. Increase (Decrease) in Deferred Revenue
LISATA THERAPEUTICS, INC. (LSTA) reported Increase (Decrease) in Deferred Revenue of $126.47 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2017-05-15
- LISATA THERAPEUTICS, INC. increase (decrease) in deferred revenue for the quarter ending 2017-03-31 was $126.47K, a 95.88% decline year-over-year.
- LISATA THERAPEUTICS, INC. increase (decrease) in deferred revenue for the quarter ending 2016-12-31 was -$513.95K.
- LISATA THERAPEUTICS, INC. increase (decrease) in deferred revenue for the quarter ending 2016-09-30 was -$844.47K, a 198.76% decline year-over-year.
- LISATA THERAPEUTICS, INC. increase (decrease) in deferred revenue for the quarter ending 2016-06-30 was $2.63M.
- LISATA THERAPEUTICS, INC. increase (decrease) in deferred revenue for fiscal 2016 was $4.34M, a 329.27% increase from fiscal 2015.
- LISATA THERAPEUTICS, INC. increase (decrease) in deferred revenue for fiscal 2015 was $1.01M, a 59.84% decline from fiscal 2014.
- LISATA THERAPEUTICS, INC. increase (decrease) in deferred revenue for fiscal 2014 was $2.52M, a 622.89% increase from fiscal 2013.
- LISATA THERAPEUTICS, INC. increase (decrease) in deferred revenue for fiscal 2013 was $348.26K, a 95.64% increase from fiscal 2012.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 3 month as first filed | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 6 month as first filed | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 9 month as first filed | Increase (Decrease) in Deferred Revenue 12 month | Increase (Decrease) in Deferred Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-03-31 | $126.47K 10-Q · filed 2017-05-15 | -$387.48K derived: sum of 2 quarters · filed 2017-05-15 | -$1.23M derived: sum of 3 quarters · filed 2017-05-15 | $1.40M derived: sum of 4 quarters · filed 2017-05-15 | ||||
| 2016-12-31 | -$513.95K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-17 | -$1.36M derived: sum of 2 quarters · filed 2017-03-17 | $1.27M derived: sum of 3 quarters · filed 2017-03-17 | $4.34M 10-K · filed 2017-03-17 | ||||
| 2016-09-30 | -$844.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $1.78M derived: sum of 2 quarters · filed 2016-11-07 | $4.85M 10-Q · filed 2016-11-07 | $4.70M derived: sum of 4 quarters · filed 2017-05-15 | ||||
| 2016-06-30 | $2.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $5.70M 10-Q · filed 2016-08-09 | $5.55M derived: sum of 3 quarters · filed 2017-05-15 | $6.40M derived: sum of 4 quarters · filed 2017-05-15 | ||||
| 2016-03-31 | $3.07M 10-Q · filed 2017-05-15 | $2.92M derived: sum of 2 quarters · filed 2017-05-15 | $3.77M derived: sum of 3 quarters · filed 2017-05-15 | $2.91M derived: sum of 4 quarters · filed 2017-05-15 | ||||
| 2015-12-31 | -$152.85K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-17 | $702.19K derived: sum of 2 quarters · filed 2017-03-17 | -$160.59K derived: sum of 3 quarters · filed 2017-03-17 | $1.01M 10-K · filed 2017-03-17 | ||||
| 2015-09-30 | $855.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$7.75K derived: sum of 2 quarters · filed 2016-11-07 | $1.16M 10-Q · filed 2016-11-07 | $1.86M derived: sum of 4 quarters · filed 2016-11-07 | ||||
| 2015-06-30 | -$862.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $308.91K 10-Q · filed 2016-08-09 | $1.00M derived: sum of 3 quarters · filed 2016-08-09 | $1.81M derived: sum of 4 quarters · filed 2016-08-09 | ||||
| 2015-03-31 | $1.17M 10-Q · filed 2016-05-05 | $1.87M derived: sum of 2 quarters · filed 2016-05-05 | $2.68M derived: sum of 3 quarters · filed 2016-05-05 | $3.47M derived: sum of 4 quarters · filed 2016-05-05 | ||||
| 2014-12-31 | $694.14K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $1.50M derived: sum of 2 quarters · filed 2016-03-15 | $2.30M derived: sum of 3 quarters · filed 2016-03-15 | $2.52M 10-K · filed 2016-03-15 | ||||
| 2014-09-30 | $809.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $1.61M derived: sum of 2 quarters · filed 2015-11-05 | $1.82M 10-Q · filed 2015-11-05 | $2.62M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2014-06-30 | $797.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $1.01M 10-Q · filed 2015-08-06 | $1.81M derived: sum of 3 quarters · filed 2016-03-15 | $2.47M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2014-03-31 | $216.51K 10-Q · filed 2015-05-06 | $1.01M derived: sum of 2 quarters · filed 2016-03-15 | $1.67M derived: sum of 3 quarters · filed 2016-03-15 | $217.86K derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2013-12-31 | $794.66K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $1.45M derived: sum of 2 quarters · filed 2016-03-15 | $1.35K derived: sum of 3 quarters · filed 2016-03-15 | $348.26K 10-K · filed 2016-03-15 | ||||
| 2013-09-30 | $659.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | -$793.31K derived: sum of 2 quarters · filed 2014-10-30 | -$446.40K 10-Q · filed 2014-10-30 | $100.12K derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-06-30 | -$1.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$1.11M 10-Q · filed 2014-08-07 | -$559.78K derived: sum of 3 quarters · filed 2015-03-02 | -$1.43M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-03-31 | $346.91K 10-Q · filed 2014-05-08 | $893.43K derived: sum of 2 quarters · filed 2015-03-02 | $27.31K derived: sum of 3 quarters · filed 2015-03-02 | $264.78K derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2012-12-31 | $546.52K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | -$319.61K derived: sum of 2 quarters · filed 2015-03-02 | -$82.13K derived: sum of 3 quarters · filed 2015-03-02 | $178.01K 10-K · filed 2015-03-02 | ||||
| 2012-09-30 | -$866.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$628.65K derived: sum of 2 quarters · filed 2013-11-07 | -$368.51K 10-Q · filed 2013-11-07 | $739.84K derived: sum of 4 quarters · filed 2013-11-07 | ||||
| 2012-06-30 | $237.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $497.61K 10-Q · filed 2013-08-08 | $1.61M derived: sum of 3 quarters · filed 2013-08-08 | $292.62K derived: sum of 4 quarters · filed 2013-08-08 | ||||
| 2012-03-31 | $260.14K 10-Q · filed 2013-05-09 | $477.63K 10-Q · filed 2012-05-11 | $1.37M derived: sum of 2 quarters · filed 2013-05-09 | $55.14K derived: sum of 3 quarters · filed 2013-05-09 | $1.78M derived: sum of 4 quarters · filed 2013-05-09 | |||
| 2011-12-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | -$205.00K derived: sum of 2 quarters · filed 2013-03-11 | $1.52M derived: sum of 3 quarters · filed 2013-03-11 | $948.45K 10-K · filed 2013-03-11 | $590.12K 10-K · filed 2012-03-20 | |||
| 2011-09-30 | -$1.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | $413.31K derived: sum of 2 quarters · filed 2012-11-13 | -$159.90K 10-Q · filed 2012-11-13 | -$1.36M 10-Q · filed 2011-11-10 | $292.73K derived: sum of 4 quarters · filed 2012-11-13 | |||
| 2011-06-30 | $1.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $1.15M 10-Q · filed 2012-08-14 | $134.20K 10-Q · filed 2011-08-12 | $1.61M derived: sum of 3 quarters · filed 2012-08-15 | $1.86M derived: sum of 4 quarters · filed 2012-08-15 | |||
| 2011-03-31 | -$573.21K 10-Q · filed 2012-05-11 | -$120.58K derived: sum of 2 quarters · filed 2012-08-15 | $135.13K derived: sum of 3 quarters · filed 2012-08-15 | |||||
| 2010-12-31 | $452.63K derived: 8-K 12 month − 10-Q 9 month · filed 2012-08-15 | $708.34K derived: sum of 2 quarters · filed 2012-08-15 | $60.59K 8-K · filed 2012-08-15 | -$336.70K 10-K · filed 2012-03-20 | ||||
| 2010-09-30 | $255.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | -$392.04K 10-Q · filed 2011-11-10 | ||||||
| 2010-06-30 | -$647.75K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |